智通财经APP获悉，今海医疗科技(02225)午后涨超5%，入通后累计涨幅接近50%。截至发稿，涨5.79%，报6.21港元，成交额1135.64万港元。
消息面上，9月7日，深交所公告，根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发生调整并自9月7日起生效。其中，今海医疗科技获纳入港股通名单。此次纳入有助拓宽股东基础、吸引长期机构投资者，并提升股份交易流动性。
值得注意的是，上半年今海医疗科技收入结构显著优化，微创手术解决方案和医疗产品相关收入2543万新加坡元，同比暴增301.5%，占总收入的74.73%，而且全部来自中国市场。财报还显示，上半年公司第一次计提了中国企业所得税，意味着今海的中国医疗业务在经营上已经跨过盈亏平衡线。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.